Identification and Characterization of ShSPI, a Kazal-Type Elastase Inhibitor from the Venom of Scolopendra Hainanum
Elastase is a globular glycoprotein and belongs to the chymotrypsin family. It is involved in several inflammatory cascades on the basis of cleaving the important connective tissue protein elastin, and is strictly regulated to a balance by several endogenous inhibitors. When elastase and its inhibitors are out of balance, severe diseases will develop, especially those involved in the cardiopulmonary system. Much attention has been attracted in seeking innovative elastase inhibitors and various advancements have been taken on clinical trials of these inhibitors. Natural functional peptides from venomous animals have been shown to have anti-protease properties. Here, we identified a kazal-type serine protease inhibitor named ShSPI from the cDNA library of the venom glands of Scolopendra hainanum. ShSPI showed significant inhibitory effects on porcine pancreatic elastase and human neutrophils elastase with Ki values of 225.83 ± 20 nM and 12.61 ± 2 nM, respectively. Together, our results suggest that ShSPI may be an excellent candidate to develop a drug for cardiopulmonary diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Toxins - 11(2019), 12 vom: 05. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Luan, Ning [VerfasserIn] |
---|
Links: |
---|
Themen: |
Arthropod Venoms |
---|
Anmerkungen: |
Date Completed 26.10.2020 Date Revised 26.10.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/toxins11120708 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM304189723 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM304189723 | ||
003 | DE-627 | ||
005 | 20231225114441.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/toxins11120708 |2 doi | |
028 | 5 | 2 | |a pubmed24n1013.xml |
035 | |a (DE-627)NLM304189723 | ||
035 | |a (NLM)31817486 | ||
035 | |a (PII)E708 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Luan, Ning |e verfasserin |4 aut | |
245 | 1 | 0 | |a Identification and Characterization of ShSPI, a Kazal-Type Elastase Inhibitor from the Venom of Scolopendra Hainanum |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.10.2020 | ||
500 | |a Date Revised 26.10.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Elastase is a globular glycoprotein and belongs to the chymotrypsin family. It is involved in several inflammatory cascades on the basis of cleaving the important connective tissue protein elastin, and is strictly regulated to a balance by several endogenous inhibitors. When elastase and its inhibitors are out of balance, severe diseases will develop, especially those involved in the cardiopulmonary system. Much attention has been attracted in seeking innovative elastase inhibitors and various advancements have been taken on clinical trials of these inhibitors. Natural functional peptides from venomous animals have been shown to have anti-protease properties. Here, we identified a kazal-type serine protease inhibitor named ShSPI from the cDNA library of the venom glands of Scolopendra hainanum. ShSPI showed significant inhibitory effects on porcine pancreatic elastase and human neutrophils elastase with Ki values of 225.83 ± 20 nM and 12.61 ± 2 nM, respectively. Together, our results suggest that ShSPI may be an excellent candidate to develop a drug for cardiopulmonary diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a ShSPI | |
650 | 4 | |a centipede | |
650 | 4 | |a human neutrophils elastase | |
650 | 4 | |a kazal-type inhibitor | |
650 | 7 | |a Arthropod Venoms |2 NLM | |
650 | 7 | |a Serine Proteinase Inhibitors |2 NLM | |
650 | 7 | |a Pancreatic Elastase |2 NLM | |
650 | 7 | |a EC 3.4.21.36 |2 NLM | |
700 | 1 | |a Zhao, Qiyu |e verfasserin |4 aut | |
700 | 1 | |a Duan, Zilei |e verfasserin |4 aut | |
700 | 1 | |a Ji, Mengyao |e verfasserin |4 aut | |
700 | 1 | |a Xing, Meichen |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Tengyu |e verfasserin |4 aut | |
700 | 1 | |a Mwangi, James |e verfasserin |4 aut | |
700 | 1 | |a Rong, Mingqiang |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jiangxin |e verfasserin |4 aut | |
700 | 1 | |a Lai, Ren |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Toxins |d 2009 |g 11(2019), 12 vom: 05. Dez. |w (DE-627)NLM199735913 |x 2072-6651 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2019 |g number:12 |g day:05 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/toxins11120708 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2019 |e 12 |b 05 |c 12 |